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A B S T R A C T
Objective: Hormonal variations during the menstrual cycle may affect emotional regulation. We aimed to
investigate the association between dysmenorrhea (the severe abdominal pain and cramps associated
with menstruation) and cognitive abilities, emotional function and sleep patterns in adolescent girls.
Moreover, we evaluated the frequency of premenstrual syndrome (PMS) in our population and then
divided them into 4 groups: subjects with only PMS; subjects with only dysmenorrhea; individuals with
both PMS and dysmenorrhea and normal subjects.
Study design: In this cross sectional study, 897 adolescent girls who had entered menarche were recruited.
Of these, 35.9% had only dysmenorrhea, 14.9% had only PMS, 32.7% had both PMS and dysmenorrhea
while 16.5% had no PMS and/or dysmenorrhea (Normal). We assessed the tests for cognitive, emotional
function and sleep patterns were compared for these groups.
Results: Individuals in the dysmenorrhea group had signiﬁcantly higher depression, aggression,
insomnia, daytime sleepiness and sleep apnea scores compared to normal controls and the PMS group,
but did not have signiﬁcantly different cognitive ability (P value <0.05). These differences were strongly
correlated to pain intensity (P < 0.001). However, there were no signiﬁcant differences between those
with only PMS and control subjects with regard to cognitive ability, emotional function and sleep pattern
tests.
Conclusions: Dysmenorrhea is highly prevalent among adolescents and appears to be associated with
depressive mood, a tendency to aggressive behavior and sleep disorders among adolescent girls.
© 2017 Elsevier B.V. All rights reserved.
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Primary dysmenorrhea is characterized by pelvic pain or
cramps in women with normal pelvic anatomy. Typically, lower* Corresponding authors.
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0301-2115/© 2017 Elsevier B.V. All rights reserved.abdominal cramping pain is restricted to before or during
menstruation and lasts for several days. Dysmenorrhea is a cyclic
event, which adversely impacts on the quality of life of women [1].
Studies in adolescent girls have reported the prevalence of
dysmenorrhea to be between 20% to 90% [2].
Hormonal variations during the menstrual cycle are related to
suicidal behavior, and sex hormone concentrations may affect the
regulation of emotions by their effects in the brain [3]. Further-
more, estrogens may inﬂuence the risk of depression and
depressive symptoms.
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symptoms than male adolescents [4]. Other studies have also
shown that higher perceived stress and anxiety/depressive
symptoms are related to increased reports of menstrual disorders
and symptoms [5,6]. Furthermore, dysmenorrhea adversely affects
mood and consequently affects the individual’s attitude, relation-
ships with family and friends, social interactions, sports activities,
and academic performance, with adverse effects including school
absenteeism, poor concentration, and failure to do homework [7].
Indeed, previous studies have shown that depression and
aggression are important features of menstrual disorders [8,9].
Much of the literature on menstrual health, has focused on the
epidemiology and etiology of premenstrual syndrome (PMS) and
premenstrual dysphoric disorder (a state characterized by severe
depressive symptoms, anxiety, and irritability) only during the
premenstrual phase [10,11]; and few studies have assessed
dysmenorrhea in adolescent girls.
The results of existing studies have been inconsistent, and it is
not clear whether dysmenorrhea is associated with sleep quality
and changing sleep patterns [12–15].
Two previous studies, in college students, have reported an
association between psychological stress and PMS and irregular
menstrual cycles [16,17]. Understanding how the experience of
dysmenorrhea inﬂuences emotional wellbeing, in girls who have
recently entered menarche may provide some insights into how to
promote wellbeing and health in adolescent girls. Such informa-
tion may be of some practical importance for parents, clinicians,
and teachers who are faced with the effect of menstrual distress on
school performance of their student. Therefore in the present study
we investigated the prevalence of dysmenorrhea as well as its
association with emotional and mood function, cognitive abilities
and sleep disorders in a large population of adolescent girls.
Materials and methods
Study population
This cross sectional study was conducted in two cities
(Mashhad and Sabzevar) in northeastern Iran during January
2015. Participants were randomly recruited from different areas in
cities, using a cluster randomization method. Written consent was
obtained from students and their parents.
Exclusion criteria were as follows: any inﬂammation and auto-
immune diseases, cancer, renal or hepatic failure, cardiovascular
disorders, chronic lung disease, diabetes, asthma, multiple
sclerosis, polycystic ovary syndrome (PCOS), chronic bronchitis,
ﬁbromyalgia, metabolic bone disease and thyroid, or parathyroid
diseases.
After these exclusion criteria were applied, 940 participants
aged 12–18 years old remained. Among whom, 897 adolescents
had the menarche at least one year before the study started. The
Ethics Committee of Mashhad University of Medical Sciences
(MUMS) approved the study.
Assessment of menstrual pattern
Answers on questions related to menstrual patterns during the
past two cycles of menstruation were collected including
menstrual cyclicity, cycle length, amount of blood loss, and
duration of ﬂow.
Dysmenorrhea was deﬁned as abdominal pain, or cramping
related to menstrual bleeding and participants rated their pains
using a scale that ranged from a score of 0 (painless) to a score of 1
(mild), 2 (moderate), 3 (severe), 4 (very severe) and a score of 5
(most severe). Subsequent, were divided target population into
two groups: those with dysmenorrhea and those without (Control)
[18].Also, participants were instructed to answer questions on the
most frequent physiological and psychological symptoms that
occurred before the onset of menses including: leg ache, backache,
nausea, vomiting, diarrhea, fatigue, irritability, appetite changes,
palpitation, poor sleep, energy depletion, feeling sad or blue,
decrease interest, tendency to cry easily and loss of concentration.
Those having at least 2 symptoms, 1 physical and 1 psychological
symptom were given a diagnosis of PMS, while those with 1
symptom or no symptoms were regarded as not having PMS [19].
For further evaluation we also categorized participants into four
groups as follows: those with only PMS, those with only
dysmenorrhea, those with both PMS and dysmenorrhea and
normal subjects.
Tests of cognitive abilities
Cognitive performance was assessed using the Cognitive
Abilities Questionnaire (CAQ). The CAQ consists of 30 items, each
of which is rated on a 5-point Likert scale (1–5) and hence a total
score ranging between 30–150. Higher scores represent better
cognition abilities. The CAQ evaluates memory, inhibitory control
and selective attention, decision making, planning, sustained
attention, social cognition and cognitive ﬂexibility. Total and
subscale scores of CAQ were recorded [20].
Tests of emotional function
Depression score: The Beck Depression Inventory (BDII) is a 21-
items self-report questionnaire. Item scores range from 0 to 3 and
the minimum and maximum total scores for the questionnaire are
0 and 63 respectively [21]. The cut-off scores are as follows:
Minimal or No depression (0–9), Mild depression (10–18),
Moderate depression (19–29) and Severe depression (30–63).
Aggression score: The 29-items with ﬁve-point Likert scale (1–
5), the Buss-Perry Aggression Questionnaire (BPAQ) has been
widely used for the assessment of overall and subscale symptom
severity aggression [22].
Tests of sleep pattern
Insomnia Severity: The Insomnia Severity Index (ISI) is a
reliable instrument that results a quantitative index of insomnia
severity [23]. The instrument involves 7 items focusing on sleep
disorder severity, sleep related satisfaction and anxiety related to
the sleeping disorder. Items are rated on a 5-point Likert scale (0–
4) and calculate to provide a total score ranging from 0 to 28.
Higher scores indicate that more severe insomnia. Scores may be
categorized as: no clinically signiﬁcant insomnia (0–7), sub-
threshold insomnia or mild (8–14), moderate insomnia (15–21)
and severe insomnia (22–28).
Severity of sleepiness: The Epworth Sleepiness Scale (ESS) is a
questionnaire-derived scale of which can be used to assess the
degree of daytime sleepiness. It is an 8-item, 4-point Likert scale
that measures the habitual likelihood to fall asleep in common
situations of daily living. Total scores range from 0 to 24. Severity of
daytime sleepiness is deﬁned based on following criteria: <10
(normal), 10–16 (mild to moderate), 16 (severe sleep apnea or
narcolepsy) [24].
Sleep apnea: This Stop-Bang Sleep apnea questionnaire is a
scoring model consisting of eight questions and is scored based on
Yes/No answers (score: 1/0). Hence, the range of the total score is
0–8.The severity code scoring the degree of sleep apnea is as
follows: low risk (0–2), Intermediate risk (3–4), High risk (5–8)
[25].
Assessment of covariate
Body mass index (BMI) was calculated as weight (kilograms)
divided by height (meter) squared. Questions associated to
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How many hours are you expose to tobacco smoke?”
Chi-square or ANOVA tests were used to compare quantitative
variables in four groups (dysmenorrhea, PMS, dysmenorrhea and
PMS, as well normal control), followed by Tukey HSD. The subjects
with different severity of dysmenorrhea and without dysmenor-
rhea (controls) were compared with ANOVA test or chi-square.
Furthermore, we conducted correlation coefﬁcient analysis be-
tween severity of pain of dysmenorrhea and other variables. All
data are expressed as mean  SD. Two-sided tests were used, and
P < 0.05 was considered statistically signiﬁcant. Statistical analyses
were performed with SPSS version 17 (SPSS Inc, Chicago, Ill., USA).
Results
Nine hundred and forty subjects (360 passive smoking and
tobacco exposure) were recruited to the study. Six hundred and
seven of the 897 subjects had criteria for a diagnosis of
dysmenorrhea (68.8%); 280 subjects were included in the control
group (31.2%). In the dysmenorrhea group 85, 187, 162, 110 and 73
subjects had mild, moderate, severe, very severe and worst pain,
respectively. Regarding the criteria for PMS, 47.6% of subjects
fulﬁlled the criteria for PMS. Altogether, 35.9%, 14.9%, and 32.7%
subjects had dysmenorrhea, PMS, both PMS and dysmenorrhea,
respectively, while 16.5% had no PMS and/or dysmenorrhea.
Moreover ANOVA and chi-square tests showed the four groups of
responders (dysmenorrhea, PMS, dysmenorrhea and PMS or
control) were well-matched for age and BMI (Table 1).
The distribution of menstrual pattern and common menstrua-
tion associated symptoms between four groups are shown in
Table 2. There were no statistically signiﬁcant differences for the
dysmenorrhea and PMS with respect to age at menarche, days of
bleeding, duration of the menstruation cycle and menstrual ﬂow.
Among menstruation-associated symptom prevalence of leg ache,
nausea, palpitation, feeling sad or blue and tendency to cry easily
are statistically signiﬁcant higher in group with both dysmenor-
rhea and PMS compared to other groups.
Tests of cognitive abilities, emotional function and sleep pattern
The control group did not perform better than the dysmenor-
rhea group with different severity of pain for most of the cognitive
ability tasks. However, the control group scored more favorably
than the dysmenorrhea group on the BDII test (depressed mood),
BPAQ (aggression behavior), insomnia severity, severity of daytime
sleepiness, and sleep apnea. In all these tests, dysmenorrhea
associated with the most severe pain group had statistically
signiﬁcant higher scores compared to control group (Table 3). A
strong correlation has been found between severity of pain and
score at depression, aggression, insomnia, daytime sleepiness, and
sleep apnea (Supplementary Table 1). There were no signiﬁcant
differences between those with PMS and control subjects with
regard to cognitive ability, emotional function and sleep pattern
tests (Supplementary Table 2).
The comparison of the scores for cognitive abilities, emotional
function and sleep pattern tests in different groups (only PMS, onlyTable 1
Characteristics of the study participants.
Normal n = 148(16.5%) PMS n = 134(14.9%) Dys
Age (years) 14.6  1.7 14.6  1.4 14.6
BMI (kg/m 2) 21.0  3.6 21.0  3.6 21.5
Smoking exposure, n(%) 53(35.5%) 48(35.9%) 102
a Using ANOVA test.
b Using chi-square test.dysmenorrhea, both PMS and dysmenorrhea as well normal
subjects) was shown in Table 4. These data showed that the
cognitive ability were similar between all four groups. However
cases with dysmenorrhea had a worse situation with respect to the
depression, aggression, severity of daytime sleepiness, and sleep
apnea compared to other groups (P < 0.05). Although there were
no statistically signiﬁcant differences between PMS and normal
subjects in the cognitive abilities, emotional function and sleep
pattern tests.
Comments
The current study focused on neuropsychological function in
subjects with dysmenorrhea, and also relating menstrual pattern
to an extensive range of neuropsychological tests.We found that
the frequency of dysmenorrhea was 68.8% among female
adolescents which is relatively low compared to other countries.
In previous studies, the frequency of dysmenorrhea was 82.2% in
Indian female students [26] and 85.5% among Omani girl
adolescents [27].
We administered a total 12 tests of cognitive abilities, emotional
function and sleep pattern. For ﬁve of these tests, relating to
depressed mood, aggression behavior, daytime sleepiness, and
sleep apnea, the control subjects scored signiﬁcantly better than
those with dysmenorrhea. However, for none of the tests of
cognitive ability, did the control subjects score better than those
with dysmenorrhea. Previous studies have assessed how facial
emotion recognition and emotional memory are affected by the
menstrual cycle [28–30]. However, this study reported no
association between dysmenorrhea and cognitive impairment in
a large sample of Iranian female adolescents. Funtana et al. have
reported that, although girls with dysmenorrhea were signiﬁcantly
more neurotic compared to those without menstrual distress,
there was no signiﬁcant difference between the two groups in
cognitive and academic tasks or in school attendance. However,
the sample size of this study was small, and was recruted from a
single school [31].
We found a signiﬁcant difference between those with
dysmenorrhea and the control with respect to depression and
aggression scores, and sleep disorders. These differences were
strongly correlated to pain severity. Rodrigues and coworker in
their study on adolescents and young adult reported that in
dysmenorrhea cases, limitations in daily living activities including
anxiety/depression was related to pain intensity (r = 0.281;
p < 0.001) [32]. Also, in a population-based study of menstrual
health covering over 2000 Indian women, the severity of
dysmenorrhea increased with the intensity of anxiety, depression,
and somatic complaints. The authors suggested that dysmenorrhea
should be viewed as one of the spectrum of medically unexplained
syndromes, also considered as a multifactorial disorder [33].
Further, there is growing evidence of a signiﬁcant association
between adolescent dysmenorrhea and mood instabilities/emo-
tional ﬂuctuations such as anger, aggression, joy, stress, intense
feeling of depression, guilt, loneliness, self-dislike, suicidal
thoughts, dissatisfaction with life and reduce quality of life [34–menorrhea n = 322(35.9%) PMS+ Dysmenorrhea n = 293(32.7%) P-value
  1.5 14.7  1.5 0.930a
  3.9 21.7  4.6 0.324a
(31.8%) 90(30.8%) 0.326b
Table 2
Distribution of menstrual pattern and common menstruation associated psychovegetative symptoms between the Dysmenorrhea and control Group.
Normal n = 148(16.5%) PMS n = 134(14.9%) Dysmenorrhea n = 322(35.9%) PMS+ Dysmenorrhea n = 293(32.7%) P-value*
Age at menarche(year), mean  SD 12.6  1.1 12.7  1.7 12.4  1.1 12.4  1.1 0.127
Average days of bleeding, n (%)
Short bleeding periods(4 days) 3(2.2) 7(5.8) 16(5.0) 17(5.7) 0.331
Normal periods (4–7 days) 126(84.8) 110(81.2) 263(81.7) 217(74.1)
Long periods(>7 day) 19(13.0) 17(13.0) 43(13.4) 59(20.2)
Duration of the menstruation cycle, n (%)
<21 days 27(18.2) 32(24.1) 64(19.9) 72(24.6) 0.658
21–35 days 113(76.1) 100(74.1) 245(76.1) 204(69.6)
>35 days 8(5.7) 2(1.8) 13(4.0) 17(5.8)
Amount of menstrual ﬂow, n (%)
Little 38(25.9) 30(22.4) 77(23.9) 59(20.0) 0.398
Moderate 109(72.8) 103(77.5) 240(74.6) 223(76.3)
Heavy 1(1.3) 1(0.07) 5(1.5) 11(3.7)
Menstruation-associated symptoms, n (%)
Leg ache 18(12.0) 28(20.7) 59(18.3) 72(24.7) 0.037
Backache 88(59.8) 82(61.6) 195(60.7) 190(65.0) 0.763
Nausea 3(2.2) 12(8.7) 14(4.3) 35(12.0) 0.010
Vomiting 1(0.9) 0(0.0) 13(4.2) 9(3.0) 0.095
Diarrhea 2(1.1) 6(4.2) 8(2.6) 11(3.9) 0.496
Appetite changes 1 (1.3) 1 (0.7) 0(0.0) 5(1.8) 0.221
Irritability 7.0(4.5) 7(5.1) 20(6.3) 22(7.4) 0.744
Fatigue 11(7.3) 13(10.0) 27(8.5) 33(11.3) 0.139
Palpitation 7(4.7) 14(10.1) 20(6.3) 37(12.7) 0.045
Energy depletion 15(10.1) 10(7.6) 34(10.7) 32(11.0) 0.631
Poor sleep 3.0(1.8) 3(2.6) 3(0.9) 3(1.1) 0.869
Feeling sad or blue 4(2.5) 12(9.0) 16(5.0) 36(12.3) 0.030
Decrease interest 16(11.0) 19(13.9) 29(8.9) 40(13.8) 0.391
Loss of concentration 34(22.9) 42(30.3) 92(28.6) 97(33.0) 0.312
Tendency to cry easily 22(15.0) 41(30.8) 55(17.0) 105(35.8) 0.047
* Using ANOVA or chi-square tests.
Table 3
Score at cognitive abilities, emotional function and sleep pattern tests in Dysmenorrhea group and control.
Severity of dysmenorrhea(n = 617) P value
Control n = 280
(31.8%)
Mild n = 85
(9.5%)
Moderate n = 187
(20.8%)
Severe n = 162
(18.1%)
Very severe n = 110
(12.3%)
Worst n = 73
(8.1%)
Test of cognitive abilities
Memory 14.1  7.8 15.1  7.8 14.3  8.0 14.5  7.5 12.5  6.0 13.4  6.8 0.211
Inhibitory control and
selective attention
15.5  6.3 16.4  6.6 15.8  6.0 16.2  5.5 15.5  5.2 16.1  5.0 0.757
Decision making 13.2  5.7 13.4  5.5 13.2  5.5 13.4  5.4 12.7  4.7 13.2  4.6 0.943
Planning 7.7  3.6 8.6  3.5 8.3  3.5 7.8  3.3 7.6  3.1 8.4  3.2 0.190
Sustain attention 8.3  3.2 8.5  3.0 8.5  2.9 8.5  3.0 8.2  2.8 8.2  3.2 0.935
Social cognition 9.9  4.0 9.9  2.9 10.5  3.0 10.0  3.1 10.5  2.7 10.1  3.2 0.464
Cognitive ﬂexibility 10.7  3.6 11.1  3.4 11.2  3.4 11.2  3.2 11.1  2.7 11.3  3.0 0.490
Total cognitive ability
task
81.4  26.2 85.7  26.3 82.2  24.7 83.8  24.0 79.6  20.5 82.4  20.3 0.566
Tests of emotional function
Depressive mood 9.2  8.2 9.6  9.0 10.0  8.8 12.1  10.5 12.1  8.5 12.9  9.7 0.002 g
Aggressive behavior 75.4  20.1 76.6  23.0 77.1  19.4 80.9  19.9 81.2  20.1 83.6  21.7 0.006 g
Tests of sleep pattern
Insomnia 3.2  5.0 3.4  5.4 3.6  5.5 4.6  6.0 4.8  6.1 5.4  6.2 <0.001 g
Daytime sleepiness 5.5  3.8 6.3  4.0 6.7  3.9 7.0  3.9 7.6  4.1 8.4  6.7 0.016
a,b,g,d,e,m
Sleep apnea 0.5  0.5 0.6  0.5 0.6  0.5 0.7  0.5 0.7  0.5 0.8  0.5 0.003a,b,g
a, b, g, d, e and m by using ANOVA test.
Signiﬁcant between control and dysmenorrhea (Severe): a.
Signiﬁcant between control and dysmenorrhea (Very severe): b.
Signiﬁcant between control and dysmenorrhea (Worst): g.
Signiﬁcant between dysmenorrhea (Mild) and dysmenorrhea (Very severe): d.
Signiﬁcant between dysmenorrhea (Mild) and dysmenorrhea (Worst): e.
Signiﬁcant between dysmenorrhea (Moderate) and dysmenorrhea (Worst): m.
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these results. However, Holmlund et al. found no differences in
personality between subject with and without dysmenorrhea [39].
Previously it has been shown that both acute and chronic pain
can disturb sleep. Additionally, some studies [12–14] though not all[15,40] have found that dysmenorrhea can decrease sleep quality
and alter sleep patterns such as REM sleep reduction. Character-
istics of sleep has stable across the menstrual cycle in healthy
female, but those with menstrual-related problems are more likely
to experience sleep disturbance [41]. However, dysmenorrhea may
Table 4
Score at cognitive abilities, emotional function and sleep pattern tests in different group.
Normal n = 148(16.5%) PMS n = 134(14.9%) Dysmenorrhea n = 322(35.9%) PMS+ Dysmenorrhea n = 293(32.7%) P-value
Test of cognitive abilities
Memory 14.6  8.3 13.3  7.3 14.3  7.5 14.6  8.0 0.585
Inhibitory control and
selective attention
15.5  6.8 14. 8  5.4 16.4  5.8 15.9  6.0 0.170
Decision making 13.0  6.1 13.0  5.3 13.4  5.3 13.4  5.5 0.842
Planning 7.8  3.7 7.5  3.5 8.2  3.4 8.2  3.6 0.284
Sustain attention 8.5  3.1 8.0  3.0 8.6  2.9 8.5  3.1 0.559
Social cognition 10.1  3.6 10.6  4.8 10.4  3.0 10.2  3.0 0.331
Cognitive ﬂexibility 11.4  3.9 10.7  3.2 11.4  3.0 11.2  3.4 0.051
Total cognitive ability task 80.5  28.0 79.0  23.1 84.0  23.2 83.4  25.0 0.270
Tests of emotional function
Depressive mood 8.0  7.8 10.6  9.3 12.0  10.0 10.9  9.2 0.002 a,g
Aggressive behavior 73.1  19.5 72.6  18.4 81.3  19.6 78.0  20.8 <0.001 b,g
Tests of sleep pattern
Insomnia 3.0  4.9 4.0  6.0 4.2  5.7 4.2  5.8 0.287
Daytime sleepiness 5.6  3.8 6.1  3.9 7.3  4.0 6.7  4.1 0.001g
Sleep apnea 0.4  0.5 0.5  0.5 0.7  0.5 0.6  0.5 <0.001 a,b,g
a, b and g by using ANOVA test.
a: Signiﬁcant between control and (PMS+ Dysmenorrhea).
b: Signiﬁcant between PMS and (PMS+ Dysmenorrhea).
g:Signiﬁcant between control and dysmenorrhea.
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syndrome signiﬁcantly increased risk for psychiatric disorders
including depression [42]. Therefore, mental health problems and
dysmenorrhea may be interrelated bidirectional, and affect each
other.
We have evaluated cognitive abilities, emotional function tests
and sleep pattern in PMS subjects compared to dysmenorrhea and
normal participants. We found that subjects with PMS did not
show signiﬁcant differences compared to the control group. In line
with our observations, there is no comprehensive studied but there
are several reports. Few reported no differences [43], although
some studies shows this differences only in isolated tasks [44,45].
In particular Keenan and colleagues evaluated several neuropsy-
chological tasks, PMS women were found to only have verbal
learning task impairment versus a group of control women
independent to menstrual cycle phase [46]. Another well-
controlled study that assessed a range of tasks, have been observed
that PMS women showed more psychomotor slowing in the luteal
phase compared to normal women [47]. Another large sample size
study assessed a relatively full series of neurocognitive tasks,
reported no differences in performance between women with PMS
and without PMS [48]. Also, in several studies, sleep pattern was
not reported with differences between PMS and non-PMS subjects
which is consistent with our results [49,50].
The present study has several strengths. Firstly, large sample
size and population based study. Secondly; our classiﬁcation of
dysmenorrhea is generally accepted. Thirdly, we also compared the
result with PMS group to conﬁrm our conclusion. A major
limitation of our study is recall bias, as all of the variables related
to menstruation were taken by recall method. Cross-sectional
design and retrospective data cannot assess causality.
In spite of these shortcomings, we feel it appropriate to
conclude that our results indicate some degree of depression,
aggression, daytime sleepiness and sleep apnea in subjects with
dysmenorrhea. Thus, it is important to identify factors related to
dysmenorrhea, and to manage the modiﬁable factors, to prevent of
dysmenorrhea and related symptoms and disorders among
adolescents. This study was noteworthy from the perspective of
public health, since dysmenorrhea is common among adolescents.
Future research of the relationships between dysmenorrhea and
mental health problems is warranted in other populations and
different ethnic groups.Grant
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